Universal Vaporizing Chest Rub

Description

Universal Vaporising Chest Rub is a topical formulation designed to function as a nasal decongestant and cough suppressant. The product is presented in a net weight of 4 ounces (113 grams).

Uses and Indications

This drug is indicated for the temporary relief of cough associated with the common cold when applied to the chest and throat. Additionally, it provides temporary relief from minor aches and pains when applied to joints and muscles.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat, or it may be rubbed onto sore, aching muscles. It is recommended to keep clothing loose around the chest and throat to facilitate the inhalation of vapors. This application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional.

For children under 2 years of age, the use of this product is not advised unless specifically directed by a healthcare provider.

Contraindications

Use is contraindicated in the following situations:

• Administration by mouth is prohibited.

• Application in the nostrils is not recommended.

• Use with tight bandages is contraindicated due to potential for restricted circulation.

• Application on wounds or damaged skin is not advised to prevent irritation or adverse reactions.

Warnings and Precautions

For external use only; direct contact with the eyes should be avoided to prevent irritation or injury.

General precautions must be observed to ensure safety. The product should be kept out of the reach of children to prevent accidental ingestion. In the event of ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following conditions occur: if a cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, if muscle aches or pain last longer than 7 days or return, medical advice should be sought.

Side Effects

Patients using this product should be aware of certain adverse reactions and warnings associated with its use. This product is intended for external use only, and contact with the eyes should be avoided to prevent irritation.

In clinical practice, patients are advised to stop use and consult a healthcare professional if they experience a cough that lasts more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, if muscle aches or pain persist for more than 7 days or return after initial improvement, patients should seek medical advice.

Before using this product, patients should consult a doctor if they have a cough that occurs with excessive phlegm (mucus) or if they have a persistent or chronic cough, such as that associated with asthma, emphysema, or smoking. These considerations are important to ensure safe and effective use of the product.

Drug Interactions

There are no documented drug interactions associated with the use of this medication. Additionally, there are no known interactions between this medication and laboratory tests. Therefore, no specific dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Universal Vaporizing Chest Rub (menthol and camphor and eucalyptus). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product unless directed by a healthcare professional. For adults and children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. This can be repeated up to three times within a 24-hour period or as directed by a physician.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The use of Universal Vaporizing Chest Rub during pregnancy does not have specific warnings, precautions, or contraindications associated with its application. Current prescribing information does not indicate any dosage modifications or safety concerns related to its use in pregnant patients. As such, healthcare professionals may consider the use of this product in pregnant individuals, although it is advisable to assess the overall clinical context and individual patient needs. Further studies may be warranted to fully understand any potential impacts on fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of Universal Vaporizing Chest Rub in lactating mothers. Additionally, there is no information available concerning the potential for excretion of the product in breast milk or any associated risks to breastfed infants while using this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider the potential risks associated with excessive administration of the medication.

It is essential to monitor patients closely for any signs or symptoms that may arise from an overdose. Symptoms may vary depending on the medication's pharmacological profile and the individual patient's response.

In the event of suspected overdosage, immediate medical intervention is recommended. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. It is advisable to consult local poison control centers or relevant medical authorities for guidance on management protocols specific to the medication in question.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective management and follow-up care. Regular monitoring of vital signs and laboratory parameters may also be warranted to assess the patient's condition and guide further treatment decisions.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. In the event of ingestion, it is crucial for patients to seek medical help or contact a Poison Control Center immediately. This information is essential for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat, and must not be frozen. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with specific instructions for different age groups. For adults and children aged 2 years and older, a thick layer should be applied to the chest and throat or on sore, aching muscles, with clothing kept loose around the chest and throat to facilitate vapor access to the nose and mouth. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare professional. For children under 2 years of age, use is not recommended unless directed by a physician.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Universal Vaporizing Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)